Breast Cancer Survival Improves Herceptin Used With Chemotherapy

[News]

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin...

More... (http://www.medicalnewstoday.com/articles/173892.php)